Microbot Medical
MBOT
27 hedge funds and large institutions have $6.1M invested in Microbot Medical in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
11% more capital invested
Capital invested by funds: $5.49M → $6.1M (+$604K)
4% more funds holding
Funds holding: 26 → 27 (+1)
0.48% more ownership
Funds ownership: 10.96% → 11.43% (+0.48%)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$98.9K |
| 2 |
VF
Virtu Financial
New York
|
+$81.3K |
| 3 |
Renaissance Technologies
New York
|
+$66.3K |
| 4 |
BlackRock
New York
|
+$5.68K |
| 5 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
+$4.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
-$24K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$14.7K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$8.78K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$6.44K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.84K |
MBOT Hedge Fund Activity: Q4 2021 in Review
27 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2021, worth a combined $6.1M — up 11% from $5.49M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBOT positions and 5 closed out — a net gain of 1 holder — while 2 added to existing stakes and 5 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $98.9K. The largest seller was Sterling Investment Advisors (Pennsylvania), exiting entirely with an estimated $24K sold.
- 27 institutional investors held Microbot Medical (MBOT) as of Q4 2021, up from 26 in Q3 2021.
- Funds reported $6.1M of Microbot Medical stock for Q4 2021, up 11% quarter-over-quarter.
- 6 funds opened new Microbot Medical positions in Q4 2021 and 5 closed out, a net change of +1 holder.
- The largest Microbot Medical buyer in Q4 2021 was Morgan Stanley, an estimated $98.9K added.
- The largest Microbot Medical seller in Q4 2021 was Sterling Investment Advisors (Pennsylvania), an estimated $24K sold.
Based on aggregated 13F filings for Q4 2021.